The LEADER trial 28 (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) studied a 1.8-mg dose in more than 9,000 patients with type 2 diabetes and found the incidence of acute pancreatitis was similar between the liraglutide and placebo groups (0.4% vs 0.5%, respectively)
Best Timing : The optimal time of day for administration to maximize efficacy (e.g., Fasted, Before Bed, Post-Workout)
One of the primary benefits of glutathione IV therapy is its ability to support detoxification at a biochemical level
Implications of oxidative stress in the pathogenesis and treatment of hyperpigmentation disorders
Cho SG, Lee YH, Park HS, Ryoo K, Kang KW, Park J, Eom SJ, Kim MJ, Chang TS, Choi SY, Shim J, Kim Y, Dong MS, Lee MJ, Kim SG, Ichijo H and Choi EJ